Novosteo, a Purdue University spin-out, has secured $500,000 in seed funding. The investor was Research Bridge Partners. Novosteo is developing a novel injectable-targeted drug for broken and compromised bones.
Source: Press Release
Novosteo, a Purdue University spin-out, has secured $500,000 in seed funding. The investor was Research Bridge Partners. Novosteo is developing a novel injectable-targeted drug for broken and compromised bones.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.